Key facts
- This page summarizes Mark E. Strome's Form 4 filing for Zivo Bioscience, Inc. (ZIVO).
- 11 reported transactions and 9 derivative rows are listed below.
- Accepted by SEC: 30 Oct 2023, 17:01.
Mark E. Strome - 02 Jun 2021 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- ZIVO
- Reported as of
- 02 Jun 2021
- Net transaction value
- +$2,810,288
- SEC form
- 4
- Accepted by SEC
- 30 Oct 2023, 17:01:28 UTC
- Next SEC filing
- 15 May 2023
- Source filing
- View source filing
- Reporting owner signature
- Mark E. Strome
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mark E. Strome filed Form 4 for Zivo Bioscience, Inc. (ZIVO) on 30 Oct 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$2,810,288.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZIVO
transaction
Common Stock
Conversion of derivative security
- Transaction value
- $2,610,288
- Shares
- +326,286
- Change %
- Price
- $8.00*
- Shares after
- 326,286
- Date
- 02 Jun 2021
- Ownership
- By entity
- Footnotes
- F1, F2, F3
ZIVO
transaction
Common Stock
Purchase
- Transaction value
- $199,600
- Shares
- +40,000
- Change %
- +24%
- Price
- $4.99
- Shares after
- 203,601
- Date
- 02 Jun 2021
- Ownership
- By trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZIVO
transaction
Derivative
Common Stock Purchase Warrant
Purchase
- Transaction value
- $400
- Shares
- +40,000
- Change %
- Price
- $0.0100*
- Shares after
- 40,000
- Date
- 02 Jun 2021
- Ownership
- By trust
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- $5.50
- Footnotes
- F3
ZIVO
transaction
Derivative
Convertible Debt
Conversion of derivative security
- Transaction value
- $0
- Shares
- -2,191,187
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 02 Jun 2021
- Ownership
- By entity
- Underlying class
- Common Stock
- Underlying amount
- 326,286
- Exercise price
- $8.00
- Footnotes
- F2, F3, F4
ZIVO
transaction
Derivative
Common Stock Purchase Warrant
Other
- Transaction value
- $0
- Shares
- -3,125
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 24 Jul 2022
- Ownership
- By entity
- Underlying class
- Common Stock
- Underlying amount
- 3,125
- Exercise price
- $8.00
- Footnotes
- F2, F3, F5
ZIVO
transaction
Derivative
Common Stock Purchase Warrant
Other
- Transaction value
- $0
- Shares
- -3,125
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 25 Sep 2022
- Ownership
- By entity
- Underlying class
- Common Stock
- Underlying amount
- 3,125
- Exercise price
- $8.00
- Footnotes
- F2, F3, F5
ZIVO
transaction
Derivative
Common Stock Purchase Warrant
Other
- Transaction value
- $0
- Shares
- -208,333
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 20 Nov 2022
- Ownership
- By entity
- Underlying class
- Common Stock
- Underlying amount
- 208,333
- Exercise price
- $8.00
- Footnotes
- F2, F3, F5
ZIVO
transaction
Derivative
Common Stock Purchase Warrant
Other
- Transaction value
- $0
- Shares
- -8,333
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 20 Nov 2022
- Ownership
- By entity
- Underlying class
- Common Stock
- Underlying amount
- 8,333
- Exercise price
- $8.00
- Footnotes
- F2, F3, F5
ZIVO
transaction
Derivative
Common Stock Purchase Warrant
Other
- Transaction value
- $0
- Shares
- -3,125
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 20 Nov 2022
- Ownership
- By entity
- Underlying class
- Common Stock
- Underlying amount
- 3,125
- Exercise price
- $8.00
- Footnotes
- F2, F3, F5
ZIVO
transaction
Derivative
Common Stock Purchase Warrant
Other
- Transaction value
- $0
- Shares
- -104,166
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 20 Nov 2022
- Ownership
- By entity
- Underlying class
- Common Stock
- Underlying amount
- 104,166
- Exercise price
- $8.00
- Footnotes
- F2, F3, F5
ZIVO
transaction
Derivative
Common Stock Purchase Warrant
Other
- Transaction value
- $0
- Shares
- -4,166
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 20 Nov 2022
- Ownership
- By entity
- Underlying class
- Common Stock
- Underlying amount
- 4,166
- Exercise price
- $8.00
- Footnotes
- F2, F3, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Mark E. Strome is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 5 footnotes
Footnote F1
The reported transaction resulted from the conversion of convertible debt into shares of common stock at $8.00.
Footnote F2
This filing is made on behalf of Strome Mezzanine Fund, L.P ("Strome Mezzanine"), Strome Alpha Fund LP ("Strome Alpha"), Strome Investment Management, LP, Strome Group, Inc., and Mark Strome (together, the "Reporting Persons"). Strome Investment Management, LP is the general partner of Strome Mezzanine. Strome Group, Inc. is the general partner of Strome Investment Management, LP. Mark Strome is the President and CEO of Strome Group, Inc. Strome Investment Management, LP, Strome Group, Inc., and Mark Strome may be deemed to share voting and investment power for the shares held by Strome Mezzanine and Strome Alpha.
Footnote F3
Pursuant to Rule 16a-1(a)(4) of the Securities Exchange Act of 1934 (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities reported herein.
Footnote F4
The convertible debt was convertible at any time prior to, and did not expire until, the repayment or conversion of the convertible debt in full.
Footnote F5
Expiration of long derivative position (warrant) without value received.